Packers Vs. A cancer campaign launched by the Packers, Bellin Health and the Vince Lombardi Cancer Foundation

The Green Bay Packers, Bellin Health and the Vince Lombardi Cancer Foundation have teamed up for the seventh year in a row to launch the Packers Vs. Cancer campaign. This initiative aims to raise awareness of all types of cancer, raise funds for research and care, and highlight the importance of early screenings in saving lives.

Packers President/CEO Mark Murphy expressed his pleasure to continue the Packers Vs. Efforts against cancer and showing support for cancer patients and their loved ones. He acknowledged the significant impact the campaign has had over the past six years and highlighted the collaboration with Bellin Health and the Vince Lombardi Cancer Foundation. The Packers organization is committed to helping fund cancer research and reminds fans to make screenings a priority.

To kick off the campaign, Packers cornerback Keisean Nixon and running back Patrick Taylor joined representatives from Bellin Health and the Vince Lombardi Cancer Foundation on the Bellin Health Cancer Team. Nixon, this year’s campaign spokesman, shared his family’s experience with cancer, adding a personal touch to the announcement.

Afterward, the group toured the Bellin Health Cancer Team facility, which offers a range of cancer treatment and support services such as medical and radiation oncology, infusion services, oncology genetics, and physical and speech therapy. Bellin Health provides approximately 15,000 infusions and a total of 10,000 radiation treatments annually.

Within this year’s tournament Packers Vs. Cancer Campaign, the new Packers Vs. A crab hat was introduced. Every sale of this hat will contribute $5 directly to the Vince Lombardi Cancer Foundation. Hat, green New Era winter knit with Packers logo on front and Packers Vs. Crab logo on the side, is currently available for purchase in store and online. In addition, shoppers at the Packers Pro Shop have the opportunity to donate $1 or more to the Vince Lombardi Cancer Foundation during their purchase through October 16, generating support for ongoing cancer research programs.